First Time Loading...

ChemoCentryx Inc
NASDAQ:CCXI

Watchlist Manager
ChemoCentryx Inc Logo
ChemoCentryx Inc
NASDAQ:CCXI
Watchlist
Price: 51.99 USD
Updated: Jun 3, 2024

ChemoCentryx Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ChemoCentryx Inc
Total Liabilities & Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
ChemoCentryx Inc
NASDAQ:CCXI
Total Liabilities & Equity
$419.4m
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities & Equity
$148.9B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities & Equity
$56.3B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Liabilities & Equity
$93B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities & Equity
$23.9B
CAGR 3-Years
25%
CAGR 5-Years
30%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities & Equity
$34.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
27%

See Also

What is ChemoCentryx Inc's Total Liabilities & Equity?
Total Liabilities & Equity
419.4m USD

Based on the financial report for Jun 30, 2022, ChemoCentryx Inc's Total Liabilities & Equity amounts to 419.4m USD.

What is ChemoCentryx Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
24%

Over the last year, the Total Liabilities & Equity growth was -10%. The average annual Total Liabilities & Equity growth rates for ChemoCentryx Inc have been 22% over the past three years , 24% over the past five years .